Table 2.
Baseline clinical characteristics of the patients (group 2).
| Patient Characteristics | (n = 36) |
|---|---|
| Medical history | |
| Paroxysmal atrial fibrillation (n, %) | 5 (13.9%) |
| Ventricular extrasystole (n, %) | 7 (19.4%) |
| Heart failure (n, %) | 7 (19.4%) |
| Hypertension (n, %) | 6 (16.7%) |
| COPD/asthma (n, %) | 8 (22.2%) |
| Diabetes mellitus (n, %) | 4 (11.1%) |
| CAD (n, %) | 7 (19.4%) |
| CVA/TIA (n, %) | 0 (0.0%) |
| Dyslipidemia (n, %) | 8 (22.2%) |
| Obesity (n, %) | 4 (11.1%) |
| Medication | |
| ACEi or ARB (n, %) | 7 (19.4%) |
| Aspirin (n, %) | 10 (27.8%) |
| β-blocker (n, %) | 8 (22.2%) |
| Calcium channel blocker (n, %) | 2 (5.6%) |
| Diuretic (n, %) | 6 (16.7%) |
COPD: chronic obstructive pulmonary disease. CAD: coronary artery disease. CVA: cerebrovascular accident. TIA: transient ischemic attack. PM: pacemaker. ICD: intracardiac defibrillator. ACEi: angiotensin-converting-enzyme inhibitor. ARB: angiotensin receptor blocker.